English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
科伦博泰递表港交所:全球ADC的先锋 丰富管线构长期价值
Mar 01, 2023 11:42 HKT
科倫博泰遞表港交所:全球ADC的先鋒 豐富管線構長期價值
Mar 01, 2023 11:41 HKT
Kingworld Medicines Earns "Shenzhen Time-honored Brand" Title Again
Feb 28, 2023 15:03 HKT
Malaysian Genomics Pivots to Biopharmaceuticals for Growth
Feb 24, 2023 17:30 HKT
乐普生物和康诺亚共同宣布与阿斯利康就CMG901达成全球独家授权协议
Feb 23, 2023 10:20 HKT
樂普生物和康諾亞共同宣佈與阿斯利康就CMG901達成全球獨家授權協定
Feb 23, 2023 10:19 HKT
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901
Feb 23, 2023 10:18 HKT
亿胜生物与复宏汉霖签订治疗年龄相关性黄斑变性全球共同开发及独家许可协议之经修订协议
Feb 22, 2023 18:50 HKT
億勝生物與復宏漢霖簽訂治療年齡相關性黃斑變性全球共同開發及獨家許可協議之經修訂協議
Feb 22, 2023 18:49 HKT
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
Feb 22, 2023 18:48 HKT
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Feb 22, 2023 14:30 HKT
Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round
Feb 16, 2023 17:09 HKT
疫苗开发不断变化的全球格局:Novotech 和 Endpoints News 网络研讨会
Feb 16, 2023 08:00 HKT
疫苗開發不斷變化的全球格局:Novotech 和 Endpoints News 網絡研討會
Feb 16, 2023 08:00 HKT
백신 개발 발전의 글로벌 환경: 노보텍 및 엔드포인트 뉴스 웨비나
Feb 16, 2023 08:00 HKT
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital
Feb 15, 2023 18:58 HKT
热烈祝贺深睿医疗俞益洲教授当选2022年ACM Fellow
Feb 15, 2023 12:16 HKT
熱烈祝賀深睿醫療俞益洲教授當選2022年ACM Fellow
Feb 15, 2023 12:15 HKT
The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar
Feb 15, 2023 09:00 HKT
欧康维视发布2022年度业绩盈利预喜
Feb 14, 2023 10:59 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: